Copyright
©The Author(s) 2019.
World J Hepatol. Mar 27, 2019; 11(3): 250-260
Published online Mar 27, 2019. doi: 10.4254/wjh.v11.i3.250
Published online Mar 27, 2019. doi: 10.4254/wjh.v11.i3.250
Table 1 Risk of bleeding, mortality and complication rate according to treatment group[11]
| Characteristics | Cyanoacrylate Group I(n = 30) | PropranololGroup II(n = 29) | No treatmentGroup III(n = 30) | P value |
| GV bleed | 10% | 38% | 53% | 0.003 |
| Bleed-related mortality | 0 | 10% | 24% | 0.034 |
| Overall mortality | 7% | 17% | 26% | 0.113 |
| Complications | 3% | 3% | 7% | 1 |
- Citation: Vine LJ, Subhani M, Acevedo JG. Update on management of gastric varices. World J Hepatol 2019; 11(3): 250-260
- URL: https://www.wjgnet.com/1948-5182/full/v11/i3/250.htm
- DOI: https://dx.doi.org/10.4254/wjh.v11.i3.250